REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Chemistry: Natural Resins Or Derivatives; Peptides Or Proteins; Lignins Or Reaction Products Thereof > Proteins, I.e., More Than 100 Amino Acid Residues > Lipoproteins, E.g., Egg Yolk Proteins, Cylomicrons, Etc. Lipoproteins, E.g., Egg Yolk Proteins, Cylomicrons, Etc.Lipoproteins, E.g., Egg Yolk Proteins, Cylomicrons, Etc. patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.12/21/06 - 20060287506 - Method for separating and concentrating biological materials using continuous-flow ultracentrifugation The present invention is directed to a method of isolating and concentrating biological materials based on their buoyant density by subjecting a sample containing the biological materials to density-gradient ultracentrifugation. In one aspect of the present invention, a method for isolating at least one biological material is provided. A sample ... 08/03/06 - 20060173168 - Bioactive peptides and unique ires elements from myelin proteolipid protein plp/dm20 Three novel low molecular weight (LMW) polypeptide fragments of a proteolipid protein human PLP/DM20 are designated PIRP-M, PIRP-L and PIRP-J, and are growth factors for oligodendrocytes with anti-apoptotic activity. They are encoded by mRNA from an IRES. Fusion polypeptides of such a LMW polypeptide, DNA encoding the LMW polypeptide and ... 01/19/06 - 20060014933 - Using amines or amino acids as mobile phase modifiers in chromatography This invention relates to the use of amine, amino acid or amino acid ester mobile phase modifiers in normal phase chromatography to improve the resolution and/or productivity of peptide and lipopeptide purification. This chromatographic method can be used for either on analytical or preparative scale purification. ... 09/15/05 - 20050203284 - Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders The present invention provides peptides and peptide analogues that mimic the structural and pharmacological properties of human ApoA-I. The peptides and peptide analogues are useful to treat a variety of disorders associated with dyslipidemia. ... ### FreshPatents.com Support |